Search

Marcella Fasso

from Richmond, CA
Age ~54
Get Report
Related to:
Alberto Fasso, 82Giulia L Fasso
Connected to:
Dominic R Fasso, 85Tosca M Fasso, 55John Fassoth, 51Elliot C Fassy, 77Allison M Fast, 68Andrea D Fast, 41Dave C Fast, 122Eileen M Fast, 61Jamye M Fast, 41Jasmine E Fast, 34

Marcella Fasso Phones & Addresses

  • 57 Southwind Cir, Richmond, CA 94804
  • Kalamazoo, MI
  • Oakland, CA
  • Palo Alto, CA

Education

Degree: Graduate or professional degree

Emails

a***[email protected]

Publications

Us Patents

Spas-1 Cancer Antigen

View page
US Patent:
20020150588, Oct 17, 2002
Filed:
Sep 13, 2001
Appl. No.:
09/952432
Inventors:
James Allison - Berkeley CA, US
Marcella Fasso - Oakland CA, US
Nilabh Shastri - Richmond CA, US
International Classification:
A61K039/00
C07H021/04
C12P021/02
C12N005/06
C07K014/435
US Classification:
424/185100, 530/350000, 435/069100, 435/325000, 435/320100, 536/023200
Abstract:
Compounds and methods for inducing protective immunity against cancer are disclosed. The compounds provided include polypeptides that contain at least one immunogenic portion of one or more SPAS-proteins and DNA molecules encoding such polypeptides. Such compounds may be formulated into vaccines and pharmaceutical compositions for immunization against cancer, or can be used for the diagnosis of cancer and the monitoring of cancer progression

Spas-1 Cancer Antigen

View page
US Patent:
20070202121, Aug 30, 2007
Filed:
Jan 29, 2007
Appl. No.:
11/699879
Inventors:
James Allison - Berkeley CA, US
Marcella Fasso - Oakland CA, US
Nilabh Shastri - Richmond CA, US
International Classification:
A61K 39/00
C07K 2/00
C12Q 1/02
US Classification:
424185100, 435029000, 530300000
Abstract:
Compounds and methods for inducing protective immunity against cancer are disclosed. The compounds provided include polypeptides that contain at least one immunogenic portion of one or more SPAS-1 proteins and DNA molecules encoding such polypeptides. Such compounds may be formulated into vaccines and pharmaceutical compositions for immunization against cancer, or can be used for the diagnosis of cancer and the monitoring of cancer progression

Immunogenic Fusion Proteins For The Treatment Of Cancer

View page
US Patent:
20180085446, Mar 29, 2018
Filed:
Sep 29, 2017
Appl. No.:
15/721641
Inventors:
- Berkeley CA, US
- Baltimore MD, US
Marcella Fasso - Richmond CA, US
Peter M. Lauer - Albany CA, US
William G. Hanson - Walnut Creek CA, US
Meredith Lai Ling Leong - Oakland CA, US
Christopher Steven Rae - Richmond CA, US
International Classification:
A61K 39/00
C12N 9/48
C12N 9/16
C07K 14/47
C12N 9/12
Abstract:
Provided herein are compositions and methods for eliciting an immune response in a subject. In particular, the present disclosure is directed to immunogenic fusion proteins and methods of eliciting an immune response using host cells comprising nucleic acid molecules encoding said fusion proteins.

Signal Peptide Fusion Partners Facilitating Listerial Expression Of Antigenic Sequences And Methods Of Preparation And Use Thereof

View page
US Patent:
20170253637, Sep 7, 2017
Filed:
May 18, 2017
Appl. No.:
15/599441
Inventors:
- BERKELEY CA, US
William G. Hanson - Walnut Creek CA, US
Justin Skoble - Berkeley CA, US
Meredith Lai Ling Leong - Oakland CA, US
Marcella Fasso - Richmond CA, US
Dirk Brockstedt - Richmond CA, US
International Classification:
C07K 14/195
Abstract:
The present invention provides nucleic acids, expression systems, and vaccine strains which provide efficient expression and secretion of antigens of interest into the cytosol of host cells, and elicit effective CD4 and CD8 T cell responses by functionally linking Listerial or other bacterial signal peptides/secretion chaperones as N-terminal fusion partners in translational reading frame with selected recombinant encoded protein antigens. These N-terminal fusion partners are deleted (either by actual deletion, by mutation, or by a combination of these approaches) for any PEST sequences native to the sequence, and/or for certain hydrophobic residues.

Immunogenic Fusion Proteins For The Treatment Of Cancer

View page
US Patent:
20160324945, Nov 10, 2016
Filed:
Apr 12, 2016
Appl. No.:
15/097271
Inventors:
- Berkeley CA, US
- Baltimore MD, US
Marcella Fasso - Richmond CA, US
Peter M. Lauer - Albany CA, US
William G. Hanson - Walnut Creek CA, US
Meredith Lai Ling Leong - Oakland CA, US
Christopher Steven Rae - Richmond CA, US
International Classification:
A61K 39/00
C12N 9/48
C12N 9/16
C12N 9/12
C07K 14/47
Abstract:
Provided herein are compositions and methods for eliciting an immune response in a subject. In particular, the present disclosure is directed to immunogenic fusion proteins and methods of eliciting an immune response using host cells comprising nucleic acid molecules encoding said fusion proteins.

Signal Peptide Fusion Partners Facilitating Listerial Expression Of Antigenic Sequences And Methods Of Preparation And Use Thereof

View page
US Patent:
20140186387, Jul 3, 2014
Filed:
Dec 27, 2013
Appl. No.:
14/142614
Inventors:
- BERKELEY CA, US
William G. Hanson - Walnut Creek CA, US
Justin Skoble - Berkeley CA, US
Meredith Lai Ling Leong - Oakland CA, US
Marcella Fasso - Richmond CA, US
Dirk Brockstedt - Richmond CA, US
Assignee:
ADURO BIOTECH, INC. - BERKELEY CA
International Classification:
C07K 14/195
US Classification:
4241901, 4353201, 4352523, 435471
Abstract:
The present invention provides nucleic acids, expression systems, and vaccine strains which provide efficient expression and secretion of antigens of interest into the cytosol of host cells, and elicit effective CD4 and CD8 T cell responses by functionally linking Listerial or other bacterial signal peptides/secretion chaperones as N-terminal fusion partners in translational reading frame with selected recombinant encoded protein antigens. These N-terminal fusion partners are deleted (either by actual deletion, by mutation, or by a combination of these approaches) for any PEST sequences native to the sequence, and/or for certain hydrophobic residues.
Control profile
Marcella Fasso from Richmond, CA, age ~54 Get Report